子分类：
| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 41 | 11-beta HSD1 inhibitors | US11703522 | 2007-02-07 | US07632838B2 | 2009-12-15 | Jason Shaoyun Xiang; Eddine Saiah; Steve Y. Tam; John C. Mckew; Lihren Chen; Manus Ipek; Huan-Qiu Li; Jianchang Li; Wei Li; Tarek Suhayl Mansour; Vipin Suri; Yuchuan Wu; Zhao-Kui Wan; Jinbo Lee; Eva Binnun; Douglas P. Wilson |
| This invention relates to inhibiting 11βHSD1. | ||||||
| 42 | PYRAZINE-2-CARBOXYAMIDE DERIVATIVES | US12470554 | 2009-05-22 | US20090233944A1 | 2009-09-17 | Georg Jaeschke; Sabine Kolczewski; Richard Hugh Phillip Porter; Eric Vieira |
| The present invention is concerned with novel pyrazine 2-carboxyamide derivatives of formula (I) wherein R1, R2 and R3 are as defined in the specification. These compounds are useful for the treatment of CNS disorders. | ||||||
| 43 | ORGANIC DYE USED IN DYE-SENSITIZED SOLAR CELL | US12237014 | 2008-09-24 | US20090043103A1 | 2009-02-12 | MARAPPAN VELUSAMY; Koilpitchai R. Justin Thomas; Jiann T'suen Lin; Kuo-Chuan Ho; Ying-Chan Hsu |
| An organic dye used in a dye-sensitized solar cell is described, having general formula (1): D-Sp1-Ch-Sp2-Acc-Y (1) wherein the groups D, Ch, Acc and Y are conjugate with each other, the group D is a donor group, the group Ch is a chromophore rendering low HOMO-LUMO gap or a polyaromatic chromophore, the group Acc is an acceptor group, the group Y is an anchoring group, and each of Sp1 and Sp2 represents a single bond or a spacer group allowing conjugation between the groups D and Ch or between the groups Ch and Acc. | ||||||
| 44 | Organic dye used in dye-sensitized solar cell | US11236935 | 2005-09-27 | US07446207B2 | 2008-11-04 | Marappan Velusamy; Koilpitchai R. Justin Thomas; Jiann T'suen Lin; Kuo-Chuan Ho; Ying-Chan Hsu |
| An organic dye used in a dye-sensitized solar cell is described, having general formula (1): D-Sp1-Ch-Sp2-Acc-Y (1) wherein the groups D, Ch, Acc and Y are conjugate with each other, the group D is a donor group, the group Ch is a chromophore rendering low HOMO-LUMO gap or a polyaromatic chromophore, the group Acc is an acceptor group, the group Y is an anchoring group, and each of Sp1 and Sp2 represents a single bond or a spacer group allowing conjugation between the groups D and Ch or between the groups Ch and Acc. | ||||||
| 45 | Selective estrogen receptor modulators containing a phenylsulfonyl group | US10521896 | 2003-07-16 | US07399867B2 | 2008-07-15 | Timothy Alan Shepherd |
| The present invention relates to a selective estrogen receptor modulator of formula I or a pharmaceutical acid addition salt thereof; useful, e.g., for treating endometriosis and/or uterine leiomyoma/leiomyomata. | ||||||
| 46 | 11-Beta HSD 1 inhibitors | US11703522 | 2007-02-07 | US20070219198A1 | 2007-09-20 | Jason Xiang; Eddine Saiah; Steve Tam; John Mckew; Lihren Chen; Manus Ipek; Katherine Lee; Huan-Qiu Li; Jianchang Li; Wei Li; Tarek Mansour; Vipin Suri; Richard Vargas; Yuchuan Wu; Zhao-Kui Wan; Jinbo Lee; Eva Binnun; Douglas Wilson |
| This invention relates to inhibiting 11βHSD1. | ||||||
| 47 | Selective estrogen receptor modulators containing a phenylsulfonyl group | US10521896 | 2003-07-16 | US20060183736A1 | 2006-08-17 | Robert Dally; Jeffrey Dodge; Scott Frank; Scott Jones; Timothy Shepherd; Owen Wallace; Kin Fong; Conrad Hummel; George Lewis |
| The present invention relates to a selective estrogen receptor modulator of formula I or a pharmaceutical acid addition salt thereof; useful, e.g., for treating endometriosis and/or uterine leiomyoma/leiomyomata. | ||||||
| 48 | HYDROPHOBIC COMPOUNDS FOR OPTICALLY ACTIVE DEVICES | EP17156329.9 | 2017-02-15 | EP3363787A1 | 2018-08-22 | The designation of the inventor has not yet been filed |
The present invention relates to novel compounds (I), particularly to compounds comprising a photoactive unit, said novel compounds being particularly suitable for compositions and ophthalmic devices as well as to compositions and ophthalmic devices comprising such compounds.
|
||||||
| 49 | COMPOUNDS FOR OPTICALLY ACTIVE DEVICES | EP17156326.5 | 2017-02-15 | EP3363786A1 | 2018-08-22 | The designation of the inventor has not yet been filed |
The present invention relates to novel compounds (I) particularly to compounds comprising a photoactive unit, said novel compounds being particularly suitable for compositions and ophthalmic devices as well as to compositions and ophthalmic devices comprising such compounds.
|
||||||
| 50 | QUINOLINE AND ISOQUINOLINE DERIVATIVES FOR TREATING PAIN AND PAIN RELATED CONDITIONS | EP16382629.0 | 2016-12-20 | EP3339304A1 | 2018-06-27 | ALMANSA-ROSALES, Carmen; YENES-MINGUEZ, Susana; VIRGILI-BERNADÓ, Marina; ALONSO-XALMA, Mónica |
The present invention relates to new compounds of formula (I):
|
||||||
| 51 | SUBSTITUTED BENZOTHIOPHENYL DERIVATIVES AS GPR40 AGONISTS FOR THE TREATMENT OF TYPE II DIABETES | EP15784860.7 | 2015-10-08 | EP3204361A1 | 2017-08-16 | KUO, Gee-Hong; PLAYER, Mark R.; YANG, Shyh-Ming; ZHANG, Yue-Mie; HUANG, Hui |
| Disclosed are compounds, compositions and methods for treating of disorders that are affected by the modulation of the GPR40 receptor. Such compounds are represented by Formula (I) as follows: wherein R1, R2, R3, R5, R6, W, and A are defined herein. | ||||||
| 52 | ARYLOSULFONAMIDES FOR THE TREATMENT OF CNS DISEASES | EP11767950.6 | 2011-09-16 | EP2616440A1 | 2013-07-24 | KOLACZKOWSKI, Marcin; KOWALSKI, Piotr; JASKOWSKA, Jolanta; MARCINKOWSKA, Monika; MITKA, Katarzyna; BUCKI, Adam; WESOLOWSKA, Anna; PAWLOWSKI, Maciej |
| Arylsulphonamide derivatives of formula (I) and pharmaceutically acceptable salts thereof. The compounds may be useful for the treatment and/or prevention of disorders of the central nervous system. | ||||||
| 53 | NOVEL M3 MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS | EP04813056 | 2004-12-03 | EP1694327A4 | 2009-11-25 | BUSCH-PETERSEN JAKOB; JIN JIAN; PALOVICH MICHAEL R; FU WEI |
| 54 | 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 3 INHIBITORS FOR THE TREATMENT OF ANDROGEN DEPENDENT DISEASES | EP02761567.3 | 2002-09-05 | EP1423381B1 | 2007-01-03 | GUZI, Timothy J.; PARUCH, Kamil; MALLAMS, Alan K.; RIVERA, Jocelyn, D.; DOLL, Ronald, J.; GIRIJAVALLABHAN, Viyyoor, M.; PACHTER, Jonathan; LIU, Yi-Tsung; SAKSENA, Anil, K. |
| There are disclosed compounds of the formula (I), prodrugs thereof, or pharmaceutically acceptable salts of the compounds or of said prodrugs which are useful as inhibitors of Type 3 17beta-Hydroxysteroid Dehydrogenase. Also disclosed are pharmaceutical compositions containing said compounds and their use for the treatment or prevention of androgen dependent diseases. | ||||||
| 55 | ２型糖尿病治療のためのＧＰＲ４０アゴニストとしての置換ベンゾチオフェニル誘導体 | JP2017518944 | 2015-10-08 | JP2017530986A | 2017-10-19 | クオ，ギー−ホン; アール． プレイヤー，マーク; ヤン，シー−ミン; チャン，ユエ−ミー; ファン，フイ |
| GPR40の調節により影響される疾患を治療するための化合物、組成物及び方法が開示される。そのような化合物は式(I)で表され、式中、R1、R2、R3、R5、R6、W、及びAは本明細書で定義される。 | ||||||
| 56 | 代謝型グルタミン酸受容体の負のアロステリックモジュレーター（ＮＡＭＳ）とその使用 | JP2016570862 | 2015-06-09 | JP2017522277A | 2017-08-10 | デビッド，ピーター コスフォード，ニコラス; ラビーンドラ−パニッカル，ダーニャ; シェフラー，ダグラス，ジェイ． |
| 本明細書には、小分子の活性な代謝型グルタミン酸塩サブタイプ−2および−3の受容体の負のアロステリックモジュレーター(NAM)、その化合物を含む組成物、並びに化合物および組成物を使用する方法が提供される。【選択図】図1 | ||||||
| 57 | レジスト組成物 | JP2011024655 | 2011-02-08 | JP5691585B2 | 2015-04-01 | 増山 達郎; 山口 訓史 |
| 58 | Pattern forming method, compound, actinic ray-sensitive or radiation-sensitive resin composition and resist film used for the method, method for manufacturing electronic device, and electronic device | JP2013017949 | 2013-01-31 | JP2014149409A | 2014-08-21 | YAMAGUCHI SHUHEI; TOMIGA TAKAMITSU; YOSHINO FUMIHIRO; FURUYA SO; SHIRAKAWA MICHIHIRO; FUJITA MITSUHIRO |
| PROBLEM TO BE SOLVED: To provide a pattern forming method by which excellent roughness performance, local pattern dimension uniformity and exposure latitude are achieved and film reduction in a pattern part can be suppressed, and to provide a compound, an actinic ray-sensitive or radiation-sensitive resin composition and a resist film used for the method, and a method for manufacturing an electronic device.SOLUTION: An actinic ray-sensitive or radiation-sensitive resin composition contains (A) a resin having a group that is decomposed under the action of an acid, and generating a polar group, (C1) a compound having a group generating a first acidic functional group by the application of an active ray or a radiation ray, and a group generating a second acidic functional group different from the first acidic functional group by the application of an active ray or a radiation ray, and (C2) a compound having two or more groups selected from groups generating a structure represented by general formulae (a), (b), (c), and (d) by the application of an active ray or a radiation ray. | ||||||
| 59 | Process for the preparation of Hiv integrase inhibitor | JP2014503917 | 2012-04-03 | JP2014511859A | 2014-05-19 | ウェンジェ リ，; クルース， フィロメン ディ; キース アール． ファンドリック，; ジョー ジュ ガオ，; ニザール ハダッド，; ジ−フイ ル，; ボ チュ，; ソニア ロドリゲス，; クリス エイチ． シナナヤキ，; ヨンダ ジャン，; ウェンジュン タン， |
| 本発明は、ＨＩＶ感染の処置に有用な式（Ｉ）の化合物またはそれらの塩の調製のための改善されたプロセスを対象とする。 特に、本発明は、ＨＩＶ感染の処置に有用な（２Ｓ）−２−ｔｅｒｔ−ブトキシ−２−（４−（２，３−ジヒドロピラノ［４，３，２−ｄｅ］キノリン−７−イル）−２−メチルキノリン−３−イル）酢酸またはその塩の調製のための改善されたプロセスを対象とする。 Ｒ
４は（ａ）、（ｂ）、（ｃ）、（ｄ）、（ｅ）、（ｆ）、（ｇ）、（ｈ）、（ｉ）、（ｊ）、（ｋ）、（ｌ）、（ｍ）、（ｎ）および（ｏ）からなる群から選択され、Ｒ
６およびＲ
７はそれぞれ独立して、Ｈ、ハロおよび（Ｃ
１〜６ ）アルキルから選択される。
|
||||||
| 60 | Selective estrogen receptor modulators, including phenylsulfonyl group | JP2010109009 | 2010-05-11 | JP5220800B2 | 2013-06-26 | ロバート・ディーン・ダリー; ジェフリー・アラン・ドッジ; スコット・アラン・フランク; スコット・アラン・ジョーンズ; ティモシー・アラン・シェパード; オーウェン・ブレンダン・ウォレス; キン・チュウ・フォン; コンラッド・ウィルソン・ハメル; ジョージ・サル・ルイス |
QQ群二维码
意见反馈
意见反馈